Page last updated: 2024-08-21

cyproterone acetate and Menopause

cyproterone acetate has been researched along with Menopause in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19906 (35.29)18.7374
1990's6 (35.29)18.2507
2000's4 (23.53)29.6817
2010's1 (5.88)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dickson, GM1
DoMinh, T; Gerbsch, S; Heinemann, LA; Schneider, HP; Schnitker, J; Strelow, F1
Zaĭdieva, IaZ1
Gerbsch, S; Rosemeier, HP; Schneider, HP; Schnitker, J; Turck, R1
Schneider, HP1
Cappagli, B; Ciaponi, M; De Simone, L; Gambacciani, M; Genazzani, AR; Orlandi, R1
Hanes, V; Heytmanek, G; Metka, M1
Drapier-Faure, E; Faure, M1
Byrjalsen, I; Christiansen, C; Riis, BJ; Thormann, L1
Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ1
Christiansen, C; Marslew, U; Riis, BJ1
Christiansen, C; Jensen, J; Riis, BJ; Strøm, V1
Christiansen, C; Jensen, J; Riis, BJ2
Christiansen, C; Johansen, JS; Riis, BJ; Rødbro, P; Thomsen, K1
Christiansen, C; Jensen, J1
Campanini, D; Facchinetti, F; Genazzani, AR; Grasso, A; Petraglia, F; Volpe, A1

Reviews

1 review(s) available for cyproterone acetate and Menopause

ArticleYear
The role of antiandrogens in hormone replacement therapy.
    Climacteric : the journal of the International Menopause Society, 2000, Volume: 3 Suppl 2

    Topics: Androgen Antagonists; Biological Availability; Body Weight; Chemistry, Pharmaceutical; Cognition; Coronary Disease; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Osteoporosis, Postmenopausal; Patient Selection; Progesterone Congeners; Treatment Outcome

2000

Trials

10 trial(s) available for cyproterone acetate and Menopause

ArticleYear
Hormone replacement therapy: lipid responses to continuous combined oestrogen and progestogen versus oestrogen monotherapy.
    Maturitas, 1992, Volume: 15, Issue:1

    Topics: Apolipoprotein A-I; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyproterone; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Triglycerides

1992
Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: correlation with serum hormone concentrations and bleeding patterns.
    Maturitas, 1992, Volume: 15, Issue:1

    Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Menopause; Middle Aged; Pregnancy Proteins; Uterine Hemorrhage

1992
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    The American journal of medicine, 1991, Volume: 90, Issue:5

    Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes

1991
Bleeding patterns during continuous combined estrogen-progestogen therapy.
    American journal of obstetrics and gynecology, 1991, Volume: 164, Issue:5 Pt 1

    Topics: Amenorrhea; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Hemorrhage; Humans; Menopause; Middle Aged; Norethindrone; Patient Compliance

1991
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Maturitas, 1989, Volume: 11, Issue:2

    Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation; Substance Withdrawal Syndrome; Time Factors

1989
Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy.
    Clinical endocrinology, 1987, Volume: 26, Issue:3

    Topics: Calcium; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Osteoporosis; Random Allocation

1987
Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1987, Volume: 1, Issue:2

    Topics: Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium-Binding Proteins; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Osteocalcin; Osteoporosis; Progesterone; Substance Withdrawal Syndrome

1987
Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.
    American journal of obstetrics and gynecology, 1988, Volume: 159, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Bone and Bones; Cholesterol, HDL; Cholesterol, LDL; Cyproterone; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogens; Estrone; Female; Gels; Humans; Lipoproteins; Menopause; Middle Aged; Minerals; Pregnancy; Smoking

1988
Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins.
    British journal of obstetrics and gynaecology, 1987, Volume: 94, Issue:2

    Topics: Androgen Antagonists; Cholesterol, HDL; Cholesterol, LDL; Cyproterone; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Hemorrhage; Humans; Lipids; Menopause; Middle Aged; Vaginal Diseases

1987
Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Maturitas, 1986, Volume: 8, Issue:4

    Topics: Adult; Cholesterol; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Endometrium; Estradiol; Estriol; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norpregnenes

1986

Other Studies

6 other study(ies) available for cyproterone acetate and Menopause

ArticleYear
Menopause management: how you can do better.
    The Journal of family practice, 2012, Volume: 61, Issue:3

    Topics: Acupuncture Therapy; Adjuvants, Immunologic; Administration, Cutaneous; Administration, Topical; Affect; Age Factors; Androgen Antagonists; Androgens; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atrophic Vaginitis; Azabicyclo Compounds; Bupropion; Cyproterone Acetate; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Dyspareunia; Estrogens; Eszopiclone; Exercise; Female; Hair; Hormone Replacement Therapy; Hot Flashes; Humans; Hypnotics and Sedatives; Libido; Life Style; Lubricants; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Minoxidil; Phytotherapy; Piperazines; Sleep Initiation and Maintenance Disorders; Spironolactone; Testosterone

2012
The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study.
    Health and quality of life outcomes, 2004, Nov-22, Volume: 2

    Topics: Adult; Cyproterone Acetate; Drug Combinations; Estradiol; Female; Female Urogenital Diseases; Germany; Gynecology; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Outcome Assessment, Health Care; Patient Satisfaction; Product Surveillance, Postmarketing; Psychometrics; Quality of Life; Surveys and Questionnaires; Women's Health

2004
[Hormonal therapy in perimenopause].
    Akusherstvo i ginekologiia, 1995, Issue:3

    Topics: Adult; Age Factors; Climacteric; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Menopause; Middle Aged; Postmenopause; Syndrome

1995
Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen.
    Maturitas, 2000, Dec-29, Volume: 37, Issue:2

    Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Factor Analysis, Statistical; Female; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Pilot Projects; Product Surveillance, Postmarketing; Surveys and Questionnaires

2000
Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy.
    Maturitas, 2001, Aug-25, Volume: 39, Issue:2

    Topics: Absorptiometry, Photon; Adipose Tissue; Body Composition; Body Weight; Calcium, Dietary; Case-Control Studies; Cyproterone Acetate; Estradiol; Female; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Prospective Studies

2001
[Hormonal assessment in a woman with acne and alopecia].
    Revue francaise de gynecologie et d'obstetrique, 1992, Volume: 87, Issue:6

    Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Dermatologic Agents; Female; Humans; Male; Menopause; Sex Factors

1992